Literature DB >> 26005700

Uncovering unique roles of LPA receptors in the tumor microenvironment.

Sue-Chin Lee1, Yuko Fujiwara1, Gabor J Tigyi1.   

Abstract

The role of the lysophospholipase D autotaxin (ATX) and lysophosphatidic acid (LPA) in cancer is emerging and represents two key players in regulating cancer progression. In this brief review, we will discuss some of our recent findings, which highlight a central role that LPA and its receptor plays in orchestrating melanoma-stroma interactions in the establishment of lung metastases. In particular, we evaluated not only the function of LPA receptors on tumor cells but also their role on host tissues and how they can influence melanoma growth and metastasis. Using the syngeneic B16F10 murine melanoma model, we made three key observations. First, our in vitro findings demonstrate that LPA receptors, specifically LPA2 and LPA5 expressed in B16F10 cells appear to have opposing roles in cell invasion; the former seems to be responsible for the high basal invasion rate of B16F10 cells while the latter is anti-invasive upon exogenous LPA stimulation. Second, we observed a profound reduction in the incidence of pulmonary melanoma metastasis in LPA1- and LPA5-knockout (KO) mice, respectively, when compared to wild-type (WT) mice. Third, no differences in terms of subcutaneous tumor growth between LPA1KO, LPA5KO and WT mice were observed. These findings suggest that LPA receptors exert different functions in melanoma cells versus host tissues in terms of invasion and metastasis.

Entities:  

Keywords:  Lysophosphatidic acid receptor; autotoxin; invasion; melanoma; metastasis; tumor microenvironment

Year:  2015        PMID: 26005700      PMCID: PMC4438998          DOI: 10.14800/rci.440

Source DB:  PubMed          Journal:  Receptors Clin Investig


  26 in total

1.  Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.

Authors:  Nicole Euer; Marina Schwirzke; Vesna Evtimova; Helmut Burtscher; Michael Jarsch; David Tarin; Ulrich H Weidle
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

Review 2.  Autotaxin and LPA receptor signaling in cancer.

Authors:  Anna J S Houben; Wouter H Moolenaar
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

Authors:  Ahmed Boucharaba; Claire-Marie Serre; Sandra Grès; Jean Sébastien Saulnier-Blache; Jean-Claude Bordet; Julien Guglielmi; Philippe Clézardin; Olivier Peyruchaud
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

5.  Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.

Authors:  Raphael Leblanc; Sue-Chin Lee; Marion David; Jean-Claude Bordet; Derek D Norman; Renukadevi Patil; Duane Miller; Debashish Sahay; Johnny Ribeiro; Philippe Clézardin; Gabor J Tigyi; Olivier Peyruchaud
Journal:  Blood       Date:  2014-10-02       Impact factor: 22.113

6.  Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction.

Authors:  G P van Nieuw Amerongen; M A Vermeer; V W van Hinsbergh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

Review 7.  LPA receptors: subtypes and biological actions.

Authors:  Ji Woong Choi; Deron R Herr; Kyoko Noguchi; Yun C Yung; Chang-Wook Lee; Tetsuji Mutoh; Mu-En Lin; Siew T Teo; Kristine E Park; Alycia N Mosley; Jerold Chun
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

Review 8.  Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.

Authors:  Semjon Willier; Elke Butt; Thomas G P Grunewald
Journal:  Biol Cell       Date:  2013-06-03       Impact factor: 4.458

Review 9.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

10.  The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.

Authors:  Andrew M Tager; Peter LaCamera; Barry S Shea; Gabriele S Campanella; Moisés Selman; Zhenwen Zhao; Vasiliy Polosukhin; John Wain; Banu A Karimi-Shah; Nancy D Kim; William K Hart; Annie Pardo; Timothy S Blackwell; Yan Xu; Jerold Chun; Andrew D Luster
Journal:  Nat Med       Date:  2007-12-09       Impact factor: 53.440

View more
  7 in total

Review 1.  Role of autotaxin in cancer stem cells.

Authors:  Dongjun Lee; Dong-Soo Suh; Sue Chin Lee; Gabor J Tigyi; Jae Ho Kim
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

Review 2.  Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Authors:  Gabor J Tigyi; Leonard R Johnson; Sue Chin Lee; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Karin Thompson; Alyssa Boler; W Shannon McCool
Journal:  J Lipid Res       Date:  2019-01-28       Impact factor: 5.922

3.  Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.

Authors:  Wei Wang; Jinhua Wu; Abir Mukherjee; Tianhai He; Xiang-Yang Wang; Yibao Ma; Xianjun Fang
Journal:  FASEB J       Date:  2020-08-26       Impact factor: 5.191

4.  Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.

Authors:  Abir Mukherjee; Yibao Ma; Fang Yuan; Yongling Gong; Zhenyu Fang; Esraa M Mohamed; Erika Berrios; Huanjie Shao; Xianjun Fang
Journal:  Neoplasia       Date:  2015-09       Impact factor: 5.715

5.  Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells.

Authors:  Susanna A Jethwa; Emma J Leah; Qifeng Zhang; Nicholas A Bright; David Oxley; Martin D Bootman; Simon A Rudge; Michael J O Wakelam
Journal:  J Cell Sci       Date:  2016-08-24       Impact factor: 5.285

6.  PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway.

Authors:  Lin Li; Shoulei Liang; Amanda R Wasylishen; Yanqin Zhang; Xueli Yang; Bingzheng Zhou; Luling Shan; Xiuxin Han; Tianyang Mu; Guowen Wang; Shunbin Xiong
Journal:  Oncotarget       Date:  2016-04-05

Review 7.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.